International Clinical Trial: CD19 CAR-T Therapy for Refractory Childhood-Onset Systemic Lupus Erythematosus

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07855302) titled 'CD19 CAR-T Therapy for Refractory Childhood-Onset Systemic Lupus Erythematosus' on Sept. 27.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Seoul National University Hospital

Condition: Childhood-Onset Systemic Lupus Erythematosus Refractory SLE CD19 CAR-T Cell Therapy

Intervention: Biological: SNUH-CD19-CAR-T Cells

Recruitment Status: Recruiting

Phase: Phase 1

Date of First Enrollment: September 14, 2026

Target Sample Size: 8

Countries of Recruitment: South Korea

To know mor...